Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease systemic scleroderma
Symptom C0020542|pulmonary hypertension
Sentences 27
PubMedID- 20810505 Prevalence of pulmonary hypertension in systemic sclerosis in european caucasians and metaanalysis of 5 studies.
PubMedID- 23740875 Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.
PubMedID- 20425528 Diagnosis and management of pulmonary hypertension in systemic sclerosis.
PubMedID- 22523431 Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
PubMedID- 26489821 Electrocardiographic detection of pulmonary hypertension in patients with systemic sclerosis using the ventricular gradient.
PubMedID- 24155365 Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension.
PubMedID- 23910607 pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric italian cohort.
PubMedID- 22130821 pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.
PubMedID- 25036561 Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary.
PubMedID- 21047671 pulmonary hypertension in systemic sclerosis.
PubMedID- 23042670 Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the university of california, san diego, shortness of breath questionnaire.
PubMedID- 26402988 Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis.
PubMedID- 20382500 Conclusion: hrct-determined severity and extent of pulmonary fibrosis may be helpful in screening for pulmonary hypertension in patients with systemic sclerosis.
PubMedID- 20722025 Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities.
PubMedID- 25146407 Objective: to study the clinical, cardiopulmonary functional and hemodynamic profiles of systemic sclerosis patients with pulmonary hypertension (ssc-pah) compared with those of idiopathic pulmonary hypertension (ipah).
PubMedID- 20526641 Early detection of pulmonary hypertension (ph) in patients with systemic sclerosis (ssc) is essential as it leads to substantial morbidity and mortality irrespective of its etiology.
PubMedID- 25332860 Potential effect of sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis.
PubMedID- 20658290 Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.
PubMedID- 25284845 Another report mentions the efficacy of infliximab treatment in a patient with lung fibrosis and pulmonary hypertension associated with advanced systemic sclerosis, refractory to conventional therapies.
PubMedID- 23499807 N-terminal pro-brain natriuretic peptide (nt-probnp), a pro-hormone secreted by the myocardium in response to various stimuli, was found to be correlated with several hemodynamic parameters in pulmonary hypertension associated with systemic sclerosis.
PubMedID- 23292818 Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
PubMedID- 25104236 Influence of pulmonary vascular reserve on exercise-induced pulmonary hypertension in patients with systemic sclerosis.
PubMedID- 25705389 A retrospective study of 70 systemic sclerosis patients with ild-associated pulmonary hypertension was unable to demonstrate any clear benefit from pah-specific therapy.
PubMedID- 21547892 Objective: to develop a score to estimate the risk of developing pulmonary hypertension (ph) in patients with systemic sclerosis (ssc).
PubMedID- 19101049 pulmonary hypertension in systemic sclerosis determines cardiac autonomic dysfunction assessed by heart rate turbulence.
PubMedID- 23372926 Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
PubMedID- 22836630 The present study was aimed at testing the prevalence of anti-endothelial cell antibodies (aeca) in systemic scleroderma (ssc) patients with and without pulmonary hypertension (ph) and in relation to the presence of pulmonary fibrosis.

Page: 1